BioNTech launches $1 billion ADS share buyback program through May 2027 to boost capital efficiency.

BioNTech SE announced a new share repurchase program allowing it to buy back up to $1 billion worth of American Depositary Shares (ADSs) until May 6, 2027. The company aims to enhance capital efficiency and support long-term value creation while maintaining financial flexibility. The repurchases will be funded from existing cash resources and are part of BioNTech's strategy to become a multi-product company by 2030. This move reflects confidence in the company's growth prospects and commitment to sustainable shareholder value.